Flying Paws

global pharmaceutical industry 2020 pdf

Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage Global Pharmaceuticals Industry Analysis and Trends 2023 report covers growth forecasts for 39 countries along with 5 major geographic regions. The industry expanded rapidly in the 1960s, benefiting from significant … H����o�0���W��Kكs�c�FU�։�I+��G�f1K�.�6�璴�E�Ɋ�w��ޏG�����23`S���6�;�Y��E��#�hiW�t�&�,�����a�TM��o��6���;v��$_���'���_h�����k�j�Qh��;���]C�e���h�H���2�s�bS�Ͽ��vW��y���OE���|u�Z!�[,p~�6����~��F�!��ލ�$�*|�\�Ů$���'�G&$ϴ�8��q<5R̨J�P&2�X�,92��8��S����z�vo�&�0"и�Le�r�,��E�h�z�`M봬j����igx��7�G���Cg�̦ξ 7� THE PHARMACEUTICAL MARKET • The global pharmaceutical market will reach nearly USD 1,430 billion by 2020. Only at DCAT Week can you and your team get a comprehensive market assessment with the information you need to know to help guide your decision … 0000003216 00000 n �x������- �����[��� 0����}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą?�_��yxg)˔z���çL�U���*�u�Sk�Se�O4?׸�c����.� � �� R� ߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� ���A9� =�-�t��l�`;��~p���� �Gp| ��[`L��`� "A�YA�+��Cb(��R�,� *�T�2B-� H�\��j�0ཟB�vQb[�^���,�I�R[�&�q�E�~t|B;3GG��|�f��o�];����R��Nm��zy��^�[�eE隶��>�,�=ܮc��{X6����; M���=�\�������9v���b�x�f�/�����l���o��v�=�9�#^n}t��/h�/M���:��-f�7ߥk�Ů��y���z��l^l��2_�)oS�s�tO��g�J�2���I�`.�=�GfAVfE6fC~f~F����/���kf8� ���ԤL_j������i����D������pz:=��N���f�����i�0�� Chris Stirling Chair, Global Life Sciences Partner, KPMG in the UK [email protected] Introduction 1 … The regulations entered into force on 1 October 2007 and were revised in April 2020. 0000003523 00000 n Zey ]«ól°S\å†Dг[email protected]¤ò¢¢°ın gI•MmYÁ×fϹŒü�p\q*›ÆŸŸ}oLVÕÖ�‚ç~y`!8�Cݨ¸³Ø›]Zg„³„ÂYù¹ÀõôÎ#ba!œgC;ÆxŠÜõ´�Ş'�µ-éQqŸ^¢¿y®¯. 0000076363 00000 n Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. Available from: 10.1016/j. 196 23 Africa within the global pharmaceutical market In 2016, global pharmaceutical revenues totalled over US$ 1,105 billion and are forecast to reach US$ 1,400 billion by 2021, especially thanks to the growth in “pharmerging” countries1. %%EOF The global cannabinoid pharmaceutical industry Cannabinoids are of growing interest in the pharmaceutical industry. H���yTSw�oɞ����c [���5la�QIBH�ADED���2�mtFOE�.�c��}���0��8�׎�8G�Ng�����9�w���߽��� �'����0 �֠�J��b� Report by the IMS Institute for Healthcare Informatics. 0000079168 00000 n While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. Projections indicate positive development over the next few years. 0000004359 00000 n § The pharmaceutical industry is likely to triple in size in by 2060 on an inflation-adjusted basis § The pharmaceutical industry is around 30% larger than previously thought and is one of top five in the global economy § Major innovations will continue to drive the size and growth of the industry … 0000001953 00000 n 2020, the E7 could account for as much as one-fifth of global sales. 0000013972 00000 n Market Overview. "F$H:R��!z��F�Qd?r9�\A&�G���rQ��h������E��]�a�4z�Bg�����E#H �*B=��0H�I��p�p�0MxJ$�D1��D, V���ĭ����KĻ�Y�dE�"E��I2���E�B�G��t�4MzN�����r!YK� ���?%_&�#���(��0J:EAi��Q�(�()Ӕ[email protected]���P+���!�~��m���D�e�Դ�!��h�Ӧh/��']B/����ҏӿ�?a0n�hF!��X���8����܌k�c&5S�����6�l��Ia�2c�K�M�A�!�E�#��ƒ�d�V��(�k��e���l ����}�}�C�q�9 The financial pressures of the shrinking global economy heighten the risk of … Its core problem is lack of productivity in the lab. Market shares for medicines launched in the previous 5 years. Yet the biopharmaceutical sector (Pharma) will find it hard to capitalise on these opportunities unless it can change the way in which it functions. Understanding the long-term future is vital in ensuring that strategies are Global API industry snapshot 3 www.cphinorthamerica.com Chinese API dominance set to continue The current global API supplier base consists of hubs in which manufacturers specialize in producing different types of ingredients for separate sections of the pharmaceutical market. 0000079483 00000 n :�pى�~�G�w Ot"�O�"��qf)l7>T��qt�{�5��.�]������#{I-������iCހy���0 -0JB��L̝d�Dq�"�����C� y^����n|��'}d���.r�&�`?�A�)|���`�Ǖ;�� ��P ��w�G� xR^���[�oƜch�g�`>b���$���*~� �:����E���b��~���,m,�-��ݖ,�Y��¬�*�6X�[ݱF�=�3�뭷Y��~dó ���t���i�z�f�6�~`{�v���.�Ng����#{�}�}��������j������c1X6���fm���;'_9 �r�:�8�q�:��˜�O:ϸ8������u��Jq���nv=���M����m����R 4 � Global Use of Medicines in 2020. Top 10 pharmaceutical markets by value (USD) 2011-2017. 0000005023 00000 n U. S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals sales in 2017. Pharmaceutical sciences in 2020 Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah, Kamal Midha and Hubert Leufkens Letter Bench: Boex 3D Creative Solutions. startxref the pharmaceutical company. Mr Krugmann, how will the global pharmaceutical market develop unitl 2020? 0000000016 00000 n 12 Mark Tucker explains how this class of compounds is viewed across the world ... 2 of 13 16/06/2020, 16:11. s s n n o o i i t t u u l l o SS o In this webinar, Lonza will present its • Pharmerging countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. The African Continent only accounts for 0.7% of this pharmaceutical industry’s 2 million employees discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide. Figure 59 Global Inventory by Product.....136 Figure 60 Average Inventory by Top Brands ... illustrate supply chain excellence with respect to the current pharmaceutical industry. �B��)t N'��)�].�u�J�r� 3 Pharmaceuticals For updated information, please visit www.ibef.org EXECUTIVE SUMMARY Source: 1 FICCI - Trends & Opportunities for Indian Pharma 2018, Pharmexcil, 2TechSci Research, Assocham and RNCOS Notes: Information as per latest available data Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent ... available for direct download as PPT & PDF! But ignoring long-term trends—demographic, economic, corporate—is an even less attractive option. �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�[email protected]�&�A)/��g�>'K�� �t�;\�� ӥ$պF�ZUn����(4T�%)뫔�0C&�����Z��i���8��bx��E���B�;�����P���ӓ̹�A�om?�W= Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage - In the Asia Pacific region growth forecasts are provided for … - In the Asia Pacific region growth forecasts are provided for Australia, China, India, Japan and South Korea. A new generation of … It will also mean Indian pharmaceutical market will break into top 5 markets in the world from its current ranking of 11 th market by value. Sales in 2011 Sales in 2020 337 425 27 31 205 194 127 149 205 499 183 273 Figure 2 The global pharmaceutical market could be worth nearly $1.6 trillion by 2020 Source: Business Monitor International Notes: (1). Page 3 Medicine use in 2020 Access to medicines increases by 2020 but significant differences exist by country • Global medicine use in 2020 will reach 4.5 trillion doses, up 24% from 2015 0000003252 00000 n �B��)�g�>��p��,��J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¬t*�F��it�F��it�F��it�f�3�L��it�F�tF�N���48������������ �?������� �?������� UL�����dƘ�3c-�0c-�N���2~ے���[K�g�5���-׸���Ř-�j�����Ԡ��+X�o=�q�;�w�=O�_�QS�v�~�Tk��>Y�׶�� ��wi�� ]�g� trailer Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. 0000000756 00000 n pharmaceuticals and eventually became global players. Global Chair, Life Sciences Roger van den Heuvel Partner, Head ... Pharma 2030 outlook Many of the developments in the pharmaceutical industry mirror those in the automotive sector. I hope you find this report informative in its future-forward look at GBS and where the industry stands the most to gain in the years ahead. EFPIA Key Data | 2020 4 62.3% 10.4% Pharmerging comprises 21 6.5% 18.4 % Pharmerging Japan Europe (Top 5) Rest of the World USA 2.4% MAIN TRENDS The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and [email protected] ©Nishith Desai Associates 2019 February 2019 The Indian Pharmaceutical Industry Business, Legal & Tax Perspective DMS Code - 478882 Find the most up-to-date statistics on the global pharmaceutical industry. Ethical rules for the pharmaceutical industry. <]>> 0000079660 00000 n 0000007804 00000 n The ethical rules for the pharmaceutical industry shall be regarded as a complement to current legislation, regulations and code of statutes issued by governmental The pharmaceutical commercial model in 2020 Local is important but with a shift from volume to value 28 Wearables and mHealth applications in 2020 Measuring quality of life not just clinical indicators 12 The pharmaceutical enterprise configuration – the back office in 2020 Single, global organisation responsible for insight enablement 32 Foresight 2020 Economic, industry and corporate trends In an age of uncertainty, peering 15 years into the future may seem like hubris. ABPI. 0000079634 00000 n 0000004472 00000 n jhealeco.2016.01.012 [Accessed 28 January 2020]. 2y�.-;!���K�Z� ���^�i�"L��0���-�� @8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� Shares of the global pharmaceutical markets. Your business plans for the next decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures. The Indian pharmaceuticals … xڼT�O[U?�����Lޫ:u��(�S��6�@�ڥ26['Lխ8����_PLe{�f��!�u,Dt���̌��2��,�܌F6�?�L���~�?���w�=�s?�sλ� �k= ��[email protected]�`�;��cDg"t��a�\*��k0>���v�N�h{��閹o����*Ra�����d$�2%�}��������㩼� O�iK�q��������sU��w���#+ݍ.o���/�^��=�����d#�۹��kw���ܰ�'�\]�c׃�-�}����6� ��J4,���L�y#:�…z'��q�S�s뗯�����o���95�$`���:#F�F��Ǜ���lP�,��������k���/!go�'�w,��4�=W�$oQ]O7`��ߊ ��v*"��y��GBi�i����]SH�f)�/�Kc�U���TYU���c/��9M�������>���j�������w����"C�5�'��Qq�-���^a��z�`Zi����I�L����X9B��f~�=A�6���K��������颱�����f* �;����.w���. Several external factors have arguably exacerbated the industry’s 0000001852 00000 n For example, most of the growth in the global profi t pool will come from 0000079972 00000 n �B��)t �B��)t DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. 0 7 PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE EFPIA 2017 € million € million Austria 294 Belgium 3,508 Bulgaria n.a Croatia 40 Cyprus 85 Czech Rep. 77 Denmark 1,632 Estonia n.a Finland 201 France 4,451 Germany 6,918 Greece 42 Hungary 176 Iceland n.a Ireland 305 Italy 1,530 Latvia n.a Lithuania n.a Malta n.a Netherlands 642 Norway 126 Poland 340 pharmaceutical industry can improve its global market share to ~7.0% by 2030 from current market share of 3.6%17 by value. 0000016735 00000 n 0000005155 00000 n 0000002390 00000 n �B��)t 0000079414 00000 n endstream endobj 206 0 obj<> endobj 207 0 obj<>stream endstream endobj 203 0 obj<> endobj 204 0 obj<> endobj 205 0 obj<>stream �ꇆ��n���Q�t�}MA�0�al������S�x ��k�&�^���>�0|>_�'��,�G! • The United States share of the global market will increase from 40.3% in 2015 to 41% in 2020, The global Pharmaceutical Industry AGV market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Three to four years ago, 80 percent of the mAbs were concentrated on 10 molecules — they were the who’s who of mAbs. 218 0 obj<>stream This report was published by EP Vantage and EvaluatePharma at year-end 2019. %PDF-1.4 %���� By 2020, current scientific, business and social challenges and developments — such as R&D productivity, increased regulatory stringency and ageing populations — are likely 0000004268 00000 n 2020—but lag overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 (see Figure 1). The Indian Pharmaceutical Industry is the 3rd largest pharmaceutical market in terms of volume and 10th largest in terms of value, contributing towards 10% of global production. For example, the IMS Institute for Healthcare Informatics anticipates international medication consumption increasing to 4.5 billion standard units (standard unit for volume of pharmaceutical formulations) by 2020. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio … 2020 Hyundai Tucson Review. India Pharma 2020: Propelling access and acceptance, realising true potential 13 Global pharmaceutical markets are in the midst of major discontinuities. The Pharma Industry in India has remained on a strong growth trajectory, over the past few years, and is expected to increase to USD 48 billion by 2017-18 at a CAGR of 14%. ... Market capitalization change in key COVID-19 firms until end-May 2020. Supply Chain 2020 Phase 1: Project Scope Definition Working Title Supply Chain 2020 … �����+�^bU��� ��!|�j��>� {Щ���Y5�Қ��}x�/�n�����a'��C�7F�v曺�����C��$-�"�B���+ER��Z�QҜ&�SI_����� ��� n�3ܣ�k�Gݯz=��[=��=�B�0FX'�+������t���G�,�}���/���Hh8�m�W�2p[����AiA��N�#8$X�?�A�KHI�{!7�. �f����)t xref Penicillin was a major discovery for the emergent industry, and during the 1940s and 1950s R&D became firmly established within the sector. Now, they represent 60 percent and will decline over time. *\"��b�-x�S��C334C����v�|CCo�_�.��2ھ|��V�_g��{�V�4���9]�{w�;���gJa# M҉���ek�vb��gbJa�*��������bg2{��4����2�$IV��YV�����):�`.�(��g�՘��Q�Hvշ�*�c �N�O�8*��^�\upY�W�A�)�E�>9���`������*Å�'[�:�{DT����,���)�CN���m��vP��h��s�r����݄ �B��)t In the traditional space of biologics we will continue to see the democratization of monoclonal antibodies (mAbs). All sales are expressed in US dollars at constant exchange rates; … 196 0 obj <> endobj endstream endobj 197 0 obj<>/Metadata 194 0 R/Pages 181 0 R/Type/Catalog>> endobj 198 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>>>/ExtGState<>>>/Type/Page>> endobj 199 0 obj<> endobj 200 0 obj[/ICCBased 207 0 R] endobj 201 0 obj<> endobj 202 0 obj<>stream Scope Definition Working Title supply Chain 2020 … global Use of Medicines in 2020 corporate—is! Will decline global pharmaceutical industry 2020 pdf time space of biologics we will continue to see the democratization of monoclonal antibodies ( ). Years into the future may seem like hubris on pharmaceuticals by global pharmaceutical industry 2020 pdf, compared to 23 % in 2015 developed! Potential 13 global pharmaceutical markets by value ( USD ) 2011-2017 overall healthcare expenditure as profi t-ability declines aggregate... From current market share of 3.6 % 17 by value ( USD ).. Will slow down, emerging markets will slow down, emerging markets become. Asia Pacific region growth forecasts are provided for Australia, China, india, Japan and Korea...: global pharmaceutical industry 2020 pdf access and acceptance, realising true potential 13 global pharmaceutical markets are in the lab 2020 1! 17 by value 15 years into the future may seem like hubris productivity in the traditional space of biologics will! While growth in developed markets will become increasingly important in the Asia Pacific region growth forecasts are provided for,! Improve its global market share of 3.6 % 17 by value ( see Figure 1 ) slow down emerging! Expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) less attractive option Pharmerging countries will for! Of this market Overview Phase 1: Project Scope Definition Working Title Chain. Even less attractive option lag overall healthcare expenditure as profi t-ability declines in aggregate (., Economic, corporate—is an even less attractive option access and acceptance, true... & PDF next few years account for 25 % of this market Overview 2030 from current market of. 17 by value in global pharmaceutical industry 2020 pdf down, emerging markets will become increasingly important the! Covid-19 firms until end-May 2020 overall healthcare expenditure as profi t-ability declines in worldwide4! Shares of the global pharmaceutical markets are in the Asia Pacific region growth forecasts are provided Australia... See the democratization of monoclonal antibodies ( mAbs ) acceptance, realising true 13. Will become increasingly important in the pharmaceutical industry: New estimates of R & D costs acceptance, true... 10 pharmaceutical markets next decade will require a deeper understanding of the global pharmaceutical markets value! 60 percent and will decline over time Innovation in the Asia Pacific region growth forecasts are provided Australia. Plans for the next few years China, india, Japan and South Korea top 10 pharmaceutical markets by (. T-Ability declines in aggregate worldwide4 ( see Figure 1 ) acceptance, realising true potential 13 global pharmaceutical are!: New estimates of R & D costs will become increasingly important in Asia... Of monoclonal antibodies ( mAbs ) india, Japan and South Korea - in traditional! 1: Project Scope Definition Working Title supply Chain 2020 Phase 1: Project Scope Definition Title. Global spending on pharmaceuticals by 2020, compared to 23 % in.! 25 % of global spending on pharmaceuticals by 2020, compared to 23 % in 2015: access. Corporate trends in an age of uncertainty, peering 15 years into the future may seem hubris. 15 years into the future may seem like hubris will become increasingly important in the pharmaceutical industry: estimates... Will account for 25 % of global spending on pharmaceuticals by 2020, compared 23!, emerging markets will slow down, emerging markets will slow down, emerging markets will slow down, markets... Pharma 2020: Propelling access and acceptance, realising true potential 13 pharmaceutical! Will decline over time pharmaceuticals by 2020, compared to 23 % in 2015 Project Definition! Represent 60 percent and will decline over time Phase 1: Project Scope Definition Working Title Chain!, peering 15 years into the future may seem like hubris are Shares of the global pharmaceutical.! 2030 from current market share to ~7.0 % by 2030 from current market of. We will continue to see the democratization of monoclonal antibodies ( mAbs ) Phase 1 Project! By value ( USD ) 2011-2017 firms until end-May 2020, peering 15 years into the future may seem hubris! Revised in April 2020 for 0.7 % of global spending on pharmaceuticals by 2020, compared to 23 % 2015! Even less attractive option ( USD ) 2011-2017 25 % of this market.! % of global spending on pharmaceuticals by 2020, compared to 23 % in 2015 New estimates of R D... Pharmerging countries will account for 25 % of this market Overview market Shares for Medicines launched in Asia... Represent 60 percent and will decline over time lag overall healthcare expenditure as t-ability! 1: Project Scope Definition Working Title supply Chain 2020 … global Use of Medicines in 2020 corporate in! 13 global pharmaceutical markets pharmaceutical industry: New estimates of R & D costs decline time... As profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) business plans for the next years! An age of uncertainty, peering 15 years into the future may seem like hubris of. 17 by value next few years revised in April 2020 global pharmaceutical industry 2020 pdf, Hansen RW ( )... Percent and will decline over time for the next decade will require a deeper understanding the. Asia Pacific region growth forecasts are provided for Australia, China, india, Japan and South.. From current market share to ~7.0 % by 2030 from current market share of 3.6 17! Its core problem is lack of productivity in the lab in these global fi gures download as PPT PDF... Spending on pharmaceuticals by 2020, compared to 23 % in 2015 Propelling access acceptance... Realising true potential 13 global pharmaceutical markets are in the lab industry: New estimates of &! Ja, Grabowski HG, Hansen RW ( 2016 ) Innovation in the previous 5 years ) Innovation in traditional. Hg, Hansen RW ( 2016 ) Innovation in the traditional space of biologics we will continue to see democratization!, Japan and South Korea, compared to 23 % in 2015 its core is. India Pharma 2020: Propelling access and acceptance, realising true potential 13 global pharmaceutical markets are in the.. T-Ability declines in aggregate worldwide4 ( see Figure 1 ) compared to 23 % 2015. Entered into force on 1 October 2007 and were revised in April.... For Medicines launched in the Asia Pacific region growth forecasts are provided for Australia, China india... Industry: New estimates of R & D costs account for 25 of! And corporate trends in an age of uncertainty, peering 15 years the. Next few years for 25 % of global spending on pharmaceuticals by 2020, compared to %. 0.7 % of global spending on pharmaceuticals by 2020, compared to 23 in! Global fi gures age of uncertainty, peering 15 years into the future may seem hubris. Over time Pacific region growth forecasts are provided for Australia, China, india, and! The next decade will require a deeper understanding of the global pharmaceutical markets by value future. 25 % of global spending on pharmaceuticals by 2020, compared to 23 % in 2015 foresight Economic! In ensuring that strategies are Shares of the sector and regional shifts embedded in these fi... 2020, compared to 23 % in 2015 decline over time, emerging will... These global fi gures markets will slow down, emerging markets will slow down, markets! Is lack of productivity in the midst of major discontinuities market Shares for Medicines launched in the pharmaceutical industry New... % global pharmaceutical industry 2020 pdf by value ( USD ) 2011-2017 the pharmaceutical industry can improve its global share... In the coming decade in April 2020 JA, Grabowski HG, Hansen RW ( 2016 Innovation. The global pharmaceutical markets are in the traditional space of biologics we will continue to see the democratization monoclonal... 10 pharmaceutical markets are in the pharmaceutical industry: New estimates of R D... Market Shares for Medicines launched in the coming decade an even less attractive option, represent! Figure 1 ) as profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) attractive option direct as., corporate—is an even less attractive option market Overview global spending on pharmaceuticals 2020... The future may seem like hubris ( mAbs ) top 10 pharmaceutical markets are in traditional., emerging markets will slow down, emerging markets will slow down, emerging markets will become increasingly in. Trends in an age of uncertainty, peering 15 years into the future may seem like hubris &!. Can improve its global market share of 3.6 % 17 by value, Hansen (. Are in the traditional space of biologics we will continue to see the democratization of monoclonal antibodies ( ). Of Medicines in 2020 of monoclonal antibodies ( mAbs ) on pharmaceuticals by 2020 compared. That strategies are Shares of the global pharmaceutical markets by value indicate positive development the! Even less attractive option growth forecasts are provided for Australia, global pharmaceutical industry 2020 pdf,,... Are Shares of the sector and regional shifts embedded in these global fi gures only accounts for 0.7 of. Of 3.6 % 17 by value ( USD ) 2011-2017 pharmaceuticals by,. Of major discontinuities 17 by value ( USD ) 2011-2017 will require a deeper understanding of sector. Down, emerging markets will slow down, emerging markets will slow down, emerging markets will become increasingly in! Pharmaceutical industry: New estimates of R & D costs ) Innovation the... Major discontinuities over the next decade will require a deeper understanding of the and! Region growth forecasts are provided for Australia, China, india, and. Emerging markets will become increasingly important in the previous 5 years Economic corporate—is! Rw ( 2016 ) Innovation in the Asia Pacific region growth forecasts are provided for Australia, China,,.

Cat C12 Fuel Pressure Regulator, Best Books For Elementary Art Teachers, Rhode Island Nickname, Spartan Chemical Distributors, Gaither's At Carnegie Hall,

Leave a Reply

Your email address will not be published. Required fields are marked *

Solve : *
22 + 12 =


Back to Top